Sign inGet started

Ellias Helen K.

Insider CIK 2001600 · SABS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SABS SAB Biotherapeutics, Inc. A Award deriv2025-12-162025-12-18150,000— $0150,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2024-11-012024-11-0520,000— $020,000SEC↗
SABS SAB Biotherapeutics, Inc. A Award deriv2024-11-012024-11-0535,000— $035,000SEC↗
SABS SAB Biotherapeutics, Inc. M Exercise deriv2023-11-242023-11-281,800$1000.00 $1.80M0SEC↗
SABS SAB Biotherapeutics, Inc. M Exercise2023-11-242023-11-282,857,142— $02,857,142SEC↗